ACR21 Previews from Creaky Joints Save
CreakyJoints will present 11 posters and two oral presentations at ACR 2021. Data was derived from their large patient database and Arthritis Power Research Registry. COVID-19 research revealed significantly high levels of anxiety, anger, depression, and social isolation, which were linked to medication interruptions and associated flares suggesting during the pandemic, patients often felt unsupported by all levels of the healthcare system.
- Changes in Patient-Reported Outcome Scores During the COVID-19 Pandemic: Data from the ArthritisPower Research Registry
- Impact of the COVID-19 Pandemic on the Quality of Life of Patients with Rheumatic Conditions: A Qualitative Analysis of Perceived Risk and Decision-Making
- Trends in Medication Interruptions and Associations with Disease Flares During a Public Health Crisis: Longitudinal Data from Patients with Autoimmune Rheumatic Disease During the COVID-19 Pandemic
- Patients and MDs approach T2T differently: Rheumatologists’ and Patients’ Mental Models for Treatment of RA Explain Low Rates of Treat-to-Target, Rheumatologists are priorities the long-term trajectory of disease, using disease activity measures, whereas patients are focused on functionality and how they might feel on new medicines – if asked to switch – and fears about unwanted side effects.
- Anxiety and Medication Interruptions During COVID-19 Linked to Increased Disease Flares